Postdoctoral position in microfluidic RNAseq-based screening for optimal T-cell expansion protocols

Develop multiplexed microfluidic RNAseq screens to improve expansion of cancer-specific autologous tumour-infiltrating lymphocytes for clinical use. The Laboratory of Biomedical Microfluidics collaborates with George Coukos’s group on miniaturized expansion assays, sequencing-library preparation and analysis. The work combines cell biology, biochemical workflow development and translational cancer research. The full-time appointment is planned from 1 January 2027 for one year, with possible renewal.

Practical cell-biology and next-generation-sequencing experience, knowledge of T-cell expansion and therapy, and an interest in technology development. Microfluidics experience is advantageous. Apply online with a cover letter of up to two pages and a combined PDF containing CV/publications, a research statement of up to three pages and three referees.